|
|
SFX by Ex Libris Inc. |
Contains information about title and source of a journal
Naslov: |
Anagliptin and sitagliptin as addâons to metformin for patients with type 2 diabetes: a 24âweek, multicentre, randomized, doubleâblind, activeâcontrolled, phaseIIIclinical trial with a 28‐week extension |
Vir: |
|
|
|
|
List of services to meet your request
Contains list of services for current record
Basic services |
|
|
Več možnosti |
|
|
© 2024 SFX by Ex Libris Inc. | Piškotki
CrossRef Omogočeno
|